1
|
Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA.
|
Proc Natl Acad Sci U S A
|
1989
|
2.65
|
2
|
Retracted
Renaturation of denatured lambda repressor requires heat shock proteins.
|
Cell
|
1990
|
2.05
|
3
|
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
|
Oncogene
|
2007
|
1.85
|
4
|
Identification of a promoter mapping within the reiterated sequences that flank the herpes simplex virus type 1 UL region.
|
J Virol
|
1993
|
1.77
|
5
|
Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.
|
Eur J Cancer
|
2003
|
1.65
|
6
|
Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly.
|
J Virol
|
1991
|
1.54
|
7
|
Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas.
|
Bone
|
2003
|
1.14
|
8
|
Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance.
|
Mol Endocrinol
|
2001
|
1.10
|
9
|
Phosphorylation of Drosophila Jun by the MAP kinase rolled regulates photoreceptor differentiation.
|
EMBO J
|
1996
|
1.05
|
10
|
Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance.
|
J Cancer Res Clin Oncol
|
2002
|
1.03
|
11
|
Selective uptake and degradation of c-Fos and v-Fos by rat liver lysosomes.
|
FEBS Lett
|
1996
|
0.99
|
12
|
Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer.
|
J Cancer Res Clin Oncol
|
2004
|
0.99
|
13
|
Biochemistry versus molecular medicine: what should we be teaching our medical students?
|
Mol Med Today
|
1999
|
0.96
|
14
|
The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF.
|
Histopathology
|
2005
|
0.96
|
15
|
EGFR, HER-2 and COX-2 levels in colorectal cancer.
|
Histopathology
|
2008
|
0.94
|
16
|
Mining microarray data to identify transcription factors expressed in naïve resting but not activated T lymphocytes.
|
Genes Immun
|
2004
|
0.90
|
17
|
Flavonoids in atherosclerosis: an overview of their mechanisms of action.
|
Curr Med Chem
|
2013
|
0.90
|
18
|
Stretch-mediated activation of selective MAPK subtypes and potentiation of AP-1 binding in human osteoblastic cells.
|
Mol Med
|
2001
|
0.88
|
19
|
Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches.
|
Curr Med Chem
|
2012
|
0.87
|
20
|
Transactivation by herpes simplex virus proteins ICP4 and ICP0 in vaccinia virus infected cells.
|
Virology
|
1991
|
0.87
|
21
|
Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC).
|
Curr Med Chem
|
2005
|
0.86
|
22
|
Single-step piperidine elution, cleavage, and recovery of premodified DNA electrotransferred on NA-45 membrane from mobility-shift gels.
|
Nucleic Acids Res
|
1993
|
0.85
|
23
|
Molecular 'palpation' of BPH: a tale of MAPK signalling?
|
Trends Mol Med
|
2001
|
0.85
|
24
|
Different TRE-related elements are distinguished by sets of DNA-binding proteins with overlapping sequence specificity.
|
Nucleic Acids Res
|
1993
|
0.84
|
25
|
Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas.
|
Mutat Res
|
2004
|
0.84
|
26
|
DNA repair mechanisms in colorectal carcinogenesis.
|
Curr Mol Med
|
2012
|
0.82
|
27
|
Peripheral targets in obesity treatment: a comprehensive update.
|
Obes Rev
|
2014
|
0.82
|
28
|
ERp29 regulates response to doxorubicin by a PERK-mediated mechanism.
|
Biochim Biophys Acta
|
2011
|
0.81
|
29
|
Structure and regulation of the growth arrest-specific (gas-1) promoter.
|
J Biol Chem
|
1993
|
0.80
|
30
|
Mechanical stress induces DNA synthesis in PDL fibroblasts by a mechanism unrelated to autocrine growth factor action.
|
FEBS Lett
|
1998
|
0.80
|
31
|
Low levels of p27 in association with deregulated p53-pRb protein status enhance tumor proliferation and chromosomal instability in non-small cell lung carcinomas.
|
Mol Med
|
2001
|
0.80
|
32
|
Intriguing issues of EGFR targeting in head and neck cancer.
|
Ann Oncol
|
2007
|
0.79
|
33
|
Rab and rho GTPases are involved in specific response of periodontal ligament fibroblasts to mechanical stretching.
|
Biochim Biophys Acta
|
1995
|
0.79
|
34
|
Retraction: renaturation of denatured lambda repressor requires heat shock proteins.
|
Cell
|
1992
|
0.78
|
35
|
Prostate cancer: horizons in the development of novel anti-cancer strategies.
|
Curr Med Chem Anticancer Agents
|
2001
|
0.77
|
36
|
A coupled Southwestern--DNase I footprinting assay.
|
Nucleic Acids Res
|
1992
|
0.77
|
37
|
Novel biomarkers assessing the calcium deposition in coronary artery disease.
|
Curr Med Chem
|
2012
|
0.77
|
38
|
Biomarkers determining cardiovascular risk in patients with kidney disease.
|
Curr Med Chem
|
2012
|
0.77
|
39
|
Induction of the CBP transcriptional co-activator early during laryngeal carcinogenesis.
|
J Cancer Res Clin Oncol
|
2002
|
0.77
|
40
|
Atypical induction of the unfolded protein response by mifepristone.
|
Endocrine
|
2010
|
0.77
|
41
|
Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas.
|
Mol Med
|
2001
|
0.76
|
42
|
p53-Targeted drugs: intelligent weapons in the tumor-suppressing arsenal.
|
J Cancer Res Clin Oncol
|
2000
|
0.76
|
43
|
ErbB/HER receptor family in breast cancer--the more we search the more we learn.
|
Ann Oncol
|
2008
|
0.76
|
44
|
Mechanical loading triggers specific biochemical responses in mandibular condylar chondrocytes.
|
Biochim Biophys Acta
|
1994
|
0.76
|
45
|
Distinguishing specific from nonspecific complexes on southwestern blots by a rapid DMS protection assay.
|
Nucleic Acids Res
|
1993
|
0.75
|
46
|
Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics.
|
Br J Cancer
|
2007
|
0.75
|
47
|
Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues.
|
Eur J Cancer
|
2004
|
0.75
|
48
|
The therapeutic potential of targeting drugs at transcription factors.
|
Expert Opin Investig Drugs
|
1999
|
0.75
|
49
|
Predictive value of biomarkers in patients with heart failure.
|
Curr Med Chem
|
2012
|
0.75
|
50
|
Type 2 diabetes mellitus and worm longevity: a transcriptional link to cure?
|
Trends Endocrinol Metab
|
2001
|
0.75
|
51
|
Molecular pathogenesis of non muscle-invasive bladder cancer: implications for novel targeted therapies.
|
Curr Mol Med
|
2011
|
0.75
|
52
|
Circulating biomarkers for the diagnosis and prognosis of heart failure.
|
Curr Med Chem
|
2009
|
0.75
|
53
|
Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment.
|
Anticancer Res
|
2000
|
0.75
|